{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:38:54Z","timestamp":1793147934041,"version":"4.5.0"},"reference-count":232,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009377","name":"Education Department of Hunan Province","doi-asserted-by":"publisher","award":["23A0078"],"award-info":[{"award-number":["23A0078"]}],"id":[{"id":"10.13039\/100009377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ30349"],"award-info":[{"award-number":["2023JJ30349"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ70043"],"award-info":[{"award-number":["2022JJ70043"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific Research Project of Hunan Education Department"},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Research Project of Hunan Health Committee","award":["202203102866"],"award-info":[{"award-number":["202203102866"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.neuroscience.2025.06.018","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T19:27:06Z","timestamp":1749497226000},"page":"267-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Fluid biomarkers of vascular cognitive Impairment: From vascular pathophysiology to potential clinical applications"],"prefix":"10.1016","volume":"579","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9606-6140","authenticated-orcid":false,"given":"Xi","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0005","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2017.09.007","article-title":"Progress toward standardized diagnosis of vascular cognitive impairment: guidelines from the Vascular impairment of cognition classification consensus study","volume":"14","author":"Skrobot","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"31","key":"10.1016\/j.neuroscience.2025.06.018_b0010","first-page":"2881","article-title":"Chinese guidelines for the diagnosis and treatment of vascular cognitive impairment (2024 edition)","volume":"104","author":"Chinese Stroke Association Vascular Cognitive Impairment Subcommittee","year":"2024","journal-title":"Zhonghua Yi Xue Za Zhi."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0015","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3233\/JAD-171097","article-title":"Differentiating between Alzheimer's disease and Vascular cognitive impairment: is the \u201cmemory versus executive function\u201d contrast still relevant?","volume":"63","author":"Andriuta","year":"2018","journal-title":"J Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0020","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11357-020-00164-6","article-title":"Neurovascular unit dysregulation, white matter disease, and executive dysfunction: the shared triad of vascular cognitive impairment and Alzheimer disease","volume":"42","author":"Levit","year":"2020","journal-title":"Geroscience."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.06.018_b0025","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1212\/WNL.39.11.1470","article-title":"Clinical significance of MRI white matter lesions in the elderly","volume":"39","author":"Hunt","year":"1989","journal-title":"Neurology."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.06.018_b0030","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/jnc.14218","article-title":"Binswanger's disease: biomarkers in the inflammatory form of vascular cognitive impairment and dementia","volume":"144","author":"Rosenberg","year":"2018","journal-title":"J Neurochem."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.06.018_b0035","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1001\/jamaneurol.2018.1073","article-title":"Advances in understanding the pathophysiology of Lacunar stroke: a review","volume":"75","author":"Regenhardt","year":"2018","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.06.018_b0040","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.3390\/ijms20102600","article-title":"Disturbance of Intracerebral fluid Clearance and blood-brain Barrier in Vascular cognitive impairment","volume":"20","author":"Ueno","year":"2019","journal-title":"Int J Mol Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0045","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41467-020-14373-2","article-title":"Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia","volume":"11","author":"Llorens","year":"2020","journal-title":"Nat Commun."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.06.018_b0050","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis","volume":"76","author":"Bridel","year":"2019","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-020-02235-6","article-title":"Brain arteriolosclerosis","volume":"141","author":"Blevins","year":"2021","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0060","doi-asserted-by":"crossref","first-page":"H87","DOI":"10.1152\/ajpheart.01206.2010","article-title":"Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats","volume":"301","author":"Pires","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0065","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ana.24712","article-title":"Development of white matter Hyperintensity is preceded by reduced Cerebrovascular reactivity","volume":"80","author":"Sam","year":"2016","journal-title":"Ann Neurol."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.06.018_b0070","doi-asserted-by":"crossref","first-page":"e00081","DOI":"10.1128\/JVI.00081-18","article-title":"Brain Large artery lymphocytic inflammation and human immunodeficiency virus-related brain arterial remodeling","volume":"92","author":"Shenoy","year":"2018","journal-title":"J Virol."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0075","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1161\/STROKEAHA.123.043399","article-title":"Immune-Neurovascular Interactions in Experimental perinatal and childhood arterial ischemic stroke","volume":"55","author":"Mallard","year":"2024","journal-title":"Stroke."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.06.018_b0080","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1017\/S0022215100139167","article-title":"Contribution to the pathogenesis of radiation-induced injury to large arteries","volume":"111","author":"Zidar","year":"1997","journal-title":"J Laryngol Otol."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108122","article-title":"Physiology and pharmacology of amyloid precursor protein","volume":"235","author":"Cho","year":"2022","journal-title":"Pharmacol Ther."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0090","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1749-6632.2000.tb06367.x","article-title":"smooth muscle cells and the pathogenesis of cerebral amyloid angiopathy: the potential role of impaired cerebrovascular a beta clearance","volume":"903","author":"Prior","year":"2000","journal-title":"Ann N Y Acad Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0095","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12875","article-title":"Arteriolar neuropathology in cerebral microvascular disease","volume":"49","author":"Fang","year":"2023","journal-title":"Neuropathol Appl Neurobiol."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/pr.57.2.4","article-title":"The blood-brain barrier\/neurovascular unit in health and disease","volume":"57","author":"Hawkins","year":"2005","journal-title":"Pharmacol Rev."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115356","article-title":"Potential pharmacological target of tight junctions to improve the BBB permeability in neonatal hypoxic-ischemic encephalopathy diseases","volume":"207","author":"Paz","year":"2023","journal-title":"Biochem Pharmacol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/156720208783565645","article-title":"Blood brain barrier in hypoxic-ischemic conditions","volume":"5","author":"Kaur","year":"2008","journal-title":"Curr Neurovasc Res."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0115","doi-asserted-by":"crossref","unstructured":"Shukla A, Bhardwaj U, Apoorva, et al. Hypoxia-Induced miR-101 Impairs Endothelial Barrier Integrity Through Altering VE-Cadherin and Claudin-5. Mol Neurobiol. 2024, 61(3): 1807-1817. DOI:10.1007\/s12035-023-03662-8.","DOI":"10.1007\/s12035-023-03662-8"},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00401-020-02174-2","article-title":"HIF-1\u03b1 is involved in blood-brain barrier dysfunction and paracellular migration of bacteria in pneumococcal meningitis","volume":"140","author":"Devraj","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.26134","article-title":"Blood-brain Barrier breakdown in relationship to Alzheimer and Vascular disease","volume":"90","author":"Lin","year":"2021","journal-title":"Ann Neurol."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neurobiolaging.2007.07.015","article-title":"Blood-brain barrier: ageing and microvascular disease\u2013systematic review and meta-analysis","volume":"30","author":"Farrall","year":"2009","journal-title":"Neurobiol Aging."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.06.018_b0135","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/1440-1681.12747","article-title":"Association of genetic polymorphisms of claudin-1 with small vessel vascular dementia","volume":"44","author":"Srinivasan","year":"2017","journal-title":"Clin Exp Pharmacol Physiol."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.06.018_b0140","first-page":"1088","article-title":"Altered expression of claudin family proteins in Alzheimer's disease and vascular dementia brains","volume":"14","author":"Romanitan","year":"2010","journal-title":"J Cell Mol Med."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.06.018_b0145","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1007\/s11357-021-00475-2","article-title":"The aging venous system: from varicosities to vascular cognitive impairment","volume":"43","author":"Moln\u00e1r","year":"2021","journal-title":"Geroscience."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1540\/jsmr.38.63","article-title":"Intimal changes in varicose veins: an ultrastructural study","volume":"38","author":"Wali","year":"2002","journal-title":"J Smooth Muscle Res."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000111256","article-title":"Anatomy of cerebral veins and sinuses","volume":"23","author":"Kili\u00e7","year":"2008","journal-title":"Front Neurol Neurosci."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.06.018_b0160","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/jnen\/nlx009","article-title":"Collagenosis of the deep Medullary veins: an underrecognized pathologic Correlate of white matter Hyperintensities and Periventricular Infarction?","volume":"76","author":"Keith","year":"2017","journal-title":"J Neuropathol Exp Neurol."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0165","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3233\/JAD-160952","article-title":"Abnormalities of cerebral deep Medullary veins on 7 tesla MRI in amnestic mild cognitive impairment and Early Alzheimer's disease: a pilot study","volume":"57","author":"Bouvy","year":"2017","journal-title":"J Alzheimers Dis."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.06.018_b0170","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.3174\/ajnr.A5327","article-title":"In vivo imaging of venous side cerebral small-vessel disease in older adults: an MRI method at 7T","volume":"38","author":"Shaaban","year":"2017","journal-title":"AJNR Am J Neuroradiol."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.06.018_b0175","doi-asserted-by":"crossref","first-page":"H1124","DOI":"10.1152\/ajpheart.00776.2018","article-title":"Role of age-related alterations of the cerebral venous circulation in the pathogenesis of vascular cognitive impairment","volume":"316","author":"Fulop","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0180","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jalz.2013.06.009","article-title":"Microvascular network alterations in the retina of patients with Alzheimer's disease","volume":"10","author":"Cheung","year":"2014","journal-title":"Alzheimers Dement."},{"issue":"9199","key":"10.1016\/j.neuroscience.2025.06.018_b0185","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(99)04804-7","article-title":"Postural dependency of the cerebral venous outflow","volume":"355","author":"Valdueza","year":"2000","journal-title":"Lancet."},{"issue":"5\u20136","key":"10.1016\/j.neuroscience.2025.06.018_b0190","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11357-018-0044-9","article-title":"Repeated valsalva maneuvers promote symptomatic manifestations of cerebral microhemorrhages: implications for the pathogenesis of vascular cognitive impairment in older adults","volume":"40","author":"Ungvari","year":"2018","journal-title":"Geroscience."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0195","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-510X(02)00283-6","article-title":"Venous collagenosis and arteriolar tortuosity in leukoaraiosis","volume":"203\u2013204","author":"Brown","year":"2002","journal-title":"J Neurol Sci."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.06.018_b0200","first-page":"1712","article-title":"Increased diameters of the internal cerebral veins and the basal veins of Rosenthal are associated with white matter Hyperintensity volume","volume":"40","author":"Houck","year":"2019","journal-title":"AJNR Am J Neuroradiol."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0205","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.720481","article-title":"A novel imaging Biomarker for cerebral small vessel disease associated with cognitive impairment: the deep-Medullary-veins score","volume":"13","author":"Xu","year":"2021","journal-title":"Front Aging Neurosci."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.06.018_b0210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11926-020-00922-7","article-title":"Is there a Brain\/Heart Interaction in Rheumatoid arthritis and seronegative Spondyloartropathies? a combined Brain\/Heart magnetic resonance imaging reveals the answer","volume":"22","author":"Markousis-Mavrogenis","year":"2020","journal-title":"Curr Rheumatol Rep."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.06.018_b0215","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/jch.14204","article-title":"Quantitative evaluation of white matter hyperintensities in patients with heart failure using an innovative magnetic resonance image analysis method: association with disrupted circadian blood pressure variation","volume":"23","author":"Komori","year":"2021","journal-title":"J Clin Hypertens (greenwich)."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.06.018_b0220","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s11357-019-00110-1","article-title":"Cerebral venous congestion promotes blood-brain barrier disruption and neuroinflammation, impairing cognitive function in mice","volume":"41","author":"Fulop","year":"2019","journal-title":"Geroscience."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0225","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s11357-021-00504-0","article-title":"Cerebral venous congestion exacerbates cerebral microhemorrhages in mice","volume":"44","author":"Nyul-Toth","year":"2022","journal-title":"Geroscience."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.06.018_b0230","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/jnc.14228","article-title":"Does pathology of small venules contribute to cerebral microinfarcts and dementia?","volume":"144","author":"Hartmann","year":"2018","journal-title":"J Neurochem."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.06.018_b0235","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1136\/jnnp.2004.044578","article-title":"Enlarged virchow-Robin spaces: do they matter?","volume":"75","author":"Barkhof","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"17","key":"10.1016\/j.neuroscience.2025.06.018_b0240","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1042\/CS20160381","article-title":"Perivascular spaces, glymphatic dysfunction, and small vessel disease","volume":"131","author":"Mestre","year":"2017","journal-title":"Clin Sci (lond)."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.06.018_b0245","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s004150050584","article-title":"MRI findings of small subcortical \u201clacunar-like\u201d infarction resulting from large vessel disease","volume":"247","author":"Adachi","year":"2000","journal-title":"J Neurol."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.06.018_b0250","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1148\/rg.274065722","article-title":"Virchow-Robin spaces at MR imaging","volume":"27","author":"Kwee","year":"2007","journal-title":"Radiographics."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.06.018_b0255","first-page":"1598","article-title":"Infraputaminal 'lacunes'","volume":"26","author":"Pullicino","year":"1995","journal-title":"Clinical and Pathological Correlations. Stroke."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0260","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/ene.14610","article-title":"Association between cortical microinfarcts and total small vessel disease burden in cerebral amyloid angiopathy on 3-tesla magnetic resonance imaging","volume":"28","author":"Ii","year":"2021","journal-title":"Eur J Neurol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0265","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jalz.2008.10.004","article-title":"Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease","volume":"5","author":"Roher","year":"2009","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0270","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.782286","article-title":"The triglyceride glucose index is a risk factor for Enlarged Perivascular space","volume":"13","author":"Cai","year":"2022","journal-title":"Front Neurol."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0275","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2147\/CIA.S404908","article-title":"Enlarged Perivascular spaces and age-related clinical diseases","volume":"18","author":"Yang","year":"2023","journal-title":"Clin Interv Aging."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.107557","article-title":"The glymphatic system and cerebral small vessel disease","volume":"33","author":"Ang","year":"2024","journal-title":"J Stroke Cerebrovasc Dis."},{"issue":"147","key":"10.1016\/j.neuroscience.2025.06.018_b0285","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci Transl Med."},{"issue":"7560","key":"10.1016\/j.neuroscience.2025.06.018_b0290","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.06.018_b0295","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.20142290","article-title":"A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules","volume":"212","author":"Aspelund","year":"2015","journal-title":"J Exp Med."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0300","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/B978-0-443-19104-6.00006-1","article-title":"The glymphatic system","volume":"209","author":"Ghanizada","year":"2025","journal-title":"Handb Clin Neurol."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.06.018_b0305","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrn.2017.29","article-title":"Not just amyloid: physiological functions of the amyloid precursor protein family","volume":"18","author":"M\u00fcller","year":"2017","journal-title":"Nat Rev Neurosci."},{"issue":"7792","key":"10.1016\/j.neuroscience.2025.06.018_b0310","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41586-019-1912-x","article-title":"VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours","volume":"577","author":"Song","year":"2020","journal-title":"Nature."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.06.018_b0315","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s12975-019-00755-2","article-title":"From stroke to dementia: a comprehensive review exposing tight Interactions between stroke and amyloid-\u03b2 formation","volume":"11","author":"Goulay","year":"2020","journal-title":"Transl Stroke Res."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0320","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fnagi.2015.00136","article-title":"Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1","volume":"7","author":"Ramanathan","year":"2015","journal-title":"Front Aging Neurosci."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.06.018_b0325","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1471-4159.2010.07002.x","article-title":"Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid \u03b2-peptide elimination from the brain","volume":"115","author":"Zlokovic","year":"2010","journal-title":"J Neurochem."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0330","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0335","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00401-021-02393-1","article-title":"Perivascular space dilation is associated with vascular amyloid-\u03b2 accumulation in the overlying cortex","volume":"143","author":"Perosa","year":"2022","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.06.018_b0340","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jnc.13932","article-title":"Hypoxia\/ischemia activate processing of amyloid precursor protein: impact of vascular dysfunction in the pathogenesis of Alzheimer's disease","volume":"140","author":"Salminen","year":"2017","journal-title":"J Neurochem."},{"issue":"6006","key":"10.1016\/j.neuroscience.2025.06.018_b0345","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1126\/science.1194516","article-title":"Peripherally applied abeta-containing inoculates induce cerebral beta-amyloidosis","volume":"330","author":"Eisele","year":"2010","journal-title":"Science."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.06.018_b0350","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nm0896-864","article-title":"Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease","volume":"2","author":"Scheuner","year":"1996","journal-title":"Nat Med."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0355","doi-asserted-by":"crossref","DOI":"10.1111\/nan.12782","article-title":"Dysfunction of the blood-brain barrier in Alzheimer's disease: evidence from human studies","volume":"48","author":"Kurz","year":"2022","journal-title":"Neuropathol Appl Neurobiol."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.06.018_b0360","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat Rev Neurol."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0365","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.nbd.2016.05.015","article-title":"Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease","volume":"93","author":"Peng","year":"2016","journal-title":"Neurobiol Dis."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0370","doi-asserted-by":"crossref","first-page":"18003","DOI":"10.1038\/nrdp.2018.3","article-title":"Vascular cognitive impairment","volume":"4","author":"van der Flier","year":"2018","journal-title":"Nat Rev Dis Primers."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.06.018_b0375","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/s12017-018-8513-y","article-title":"Plasma \u03b2-amyloids and tau proteins in patients with Vascular cognitive impairment","volume":"20","author":"Tang","year":"2018","journal-title":"Neuromolecular Med."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0380","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1471-4159.2007.04763.x","article-title":"Blood-based neurochemical diagnosis of vascular dementia: a pilot study","volume":"103","author":"Bibl","year":"2007","journal-title":"J Neurochem."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0385","doi-asserted-by":"crossref","unstructured":"Stefani A, Bernardini S, Panella M, et al. AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis. J Neurol Sci. 2005, 237(1-2): 83-88. DOI:10.1016\/j.jns.2005.05.016.","DOI":"10.1016\/j.jns.2005.05.016"},{"issue":"9","key":"10.1016\/j.neuroscience.2025.06.018_b0390","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.neurobiolaging.2015.05.013","article-title":"Cytokine profiles and the role of cellular prion protein in patients with vascular dementia and vascular encephalopathy","volume":"36","author":"Schmitz","year":"2015","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0395","article-title":"CSF Biomarkers profile in CADASIL-A model of pure Vascular dementia: usefulness in differential diagnosis in the dementia Disorder","volume":"2010","author":"Formichi","year":"2010","journal-title":"Int J Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.06.018_b0400","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.3233\/JAD-230680","article-title":"Diagnostic performance of cerebrospinal fluid neurofilament light chain and soluble amyloid-\u03b2 protein precursor \u03b2 in the subcortical small vessel type of dementia","volume":"96","author":"Axelsson Andr\u00e9n","year":"2023","journal-title":"J Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0405","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/alz.13607","article-title":"Contributions of amyloid beta and cerebral small vessel disease in clinical decline","volume":"20","author":"Moonen","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0410","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13195-023-01307-5","article-title":"Independent effect of a\u03b2 burden on cognitive impairment in patients with small subcortical infarction","volume":"15","author":"Kang","year":"2023","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0415","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.570045","article-title":"Tau protein and its role in blood-brain Barrier dysfunction","volume":"13","author":"Michalicova","year":"2020","journal-title":"Front Mol Neurosci."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0420","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cbi.2014.12.006","article-title":"An alkaline phosphatase transport mechanism in the pathogenesis of Alzheimer's disease and neurodegeneration","volume":"226","author":"Pike","year":"2015","journal-title":"Chem Biol Interact."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0425","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00702-022-02471-y","article-title":"Tau proteins in blood as biomarkers of Alzheimer's disease and other proteinopathies","volume":"129","author":"Verde","year":"2022","journal-title":"J Neural Transm (vienna)."},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2025.06.018_b0430","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2005.03.051","article-title":"Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia","volume":"383","author":"Jia","year":"2005","journal-title":"Neurosci Lett."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.06.018_b0435","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/cns.12814","article-title":"Evaluation of cerebrospinal fluid phosphorylated tau(231) as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia","volume":"24","author":"Ki\u0111emet-Piska\u010d","year":"2018","journal-title":"CNS Neurosci Ther."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-150614","article-title":"Cerebrospinal fluid anti-amyloid-\u03b2 autoantibodies and amyloid PET in cerebral amyloid angiopathy-related inflammation","volume":"50","author":"Carmona-Iragui","year":"2016","journal-title":"J Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0445","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/1533317513507374","article-title":"Cerebrospinal fluid \u03c4 protein in differential diagnosis of Alzheimer's disease and vascular dementia in chinese population: a meta-analysis","volume":"29","author":"Liu","year":"2014","journal-title":"Am J Alzheimers Dis Other Demen."},{"issue":"Suppl 1","key":"10.1016\/j.neuroscience.2025.06.018_b0450","first-page":"31","article-title":"Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia","volume":"32","author":"Boban","year":"2008","journal-title":"Coll Antropol."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0455","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1468-1331.2003.00562.x","article-title":"CSF tau protein and beta-amyloid (1-42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the greek population","volume":"10","author":"Kapaki","year":"2003","journal-title":"Eur J Neurol."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0460","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1468-1331.2008.02387.x","article-title":"CSF biomarker profile and diagnostic value in vascular dementia","volume":"16","author":"Paraskevas","year":"2009","journal-title":"Eur J Neurol."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.06.018_b0465","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/gerona\/61.7.755","article-title":"Cerebrospinal fluid amyloid beta42\/phosphorylated tau ratio discriminates between Alzheimer's disease and vascular dementia","volume":"61","author":"de Jong","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.06.018_b0470","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0475","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3233\/JAD-200680","article-title":"The impact of amyloid-\u03b2 or tau on cognitive change in the presence of severe Cerebrovascular disease","volume":"78","author":"Jang","year":"2020","journal-title":"J Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0480","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3390\/ijms23020616","article-title":"Neuroinflammation: a potential risk for dementia","volume":"23","author":"Ahmad","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0485","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3390\/ijms22031062","article-title":"Pathomechanism Characterization and potential therapeutics identification for Parkinson's disease Targeting neuroinflammation","volume":"22","author":"Chen","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.06.018_b0490","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1136\/jnnp-2014-309421","article-title":"Validation of biomarkers in subcortical ischaemic vascular disease of the binswanger type: approach to targeted treatment trials","volume":"86","author":"Rosenberg","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0495","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.789602","article-title":"Erythrocytes are an independent protective factor for Vascular cognitive impairment in patients with severe white matter Hyperintensities","volume":"14","author":"Tao","year":"2022","journal-title":"Front Aging Neurosci."},{"issue":"Pt 2","key":"10.1016\/j.neuroscience.2025.06.018_b0500","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/brain\/awp298","article-title":"Pharmacological prion protein silencing accelerates central nervous system autoimmune disease via T cell receptor signalling","volume":"133","author":"Hu","year":"2010","journal-title":"Brain."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.06.018_b0505","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/01.STR.0000217262.03192.d4","article-title":"Deletion of cellular prion protein results in reduced akt activation, enhanced postischemic caspase-3 activation, and exacerbation of ischemic brain injury","volume":"37","author":"Weise","year":"2006","journal-title":"Stroke."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0510","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-nutr-071715-050947","article-title":"Homocysteine, B vitamins, and cognitive impairment","volume":"36","author":"Smith","year":"2016","journal-title":"Annu Rev Nutr."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000437098","article-title":"Homocysteine-induced endothelial dysfunction","volume":"67","author":"Lai","year":"2015","journal-title":"Ann Nutr Metab."},{"issue":"Pt 1","key":"10.1016\/j.neuroscience.2025.06.018_b0520","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/brain\/awg006","article-title":"Homocysteine and brain atrophy on MRI of non-demented elderly","volume":"126","author":"den Heijer","year":"2003","journal-title":"Brain."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0525","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3233\/JAD-210166","article-title":"Relationship of Homocysteine plasma levels with mild cognitive impairment, Alzheimer's disease, Vascular dementia, psychobehavioral, and functional complications","volume":"82","author":"Lauriola","year":"2021","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0530","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3389\/fnagi.2017.00169","article-title":"Vitamin D, Homocysteine, and folate in subcortical Vascular dementia and Alzheimer dementia","volume":"9","author":"Moretti","year":"2017","journal-title":"Front Aging Neurosci."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.06.018_b0535","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/jnnp-2019-322366","article-title":"Serum homocysteine and risk of dementia in Japan","volume":"91","author":"Chen","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.06.018_b0540","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/ana.24145","article-title":"Homocysteine exacerbates \u03b2-amyloid pathology, tau pathology, and cognitive deficit in a mouse model of Alzheimer disease with plaques and tangles","volume":"75","author":"Li","year":"2014","journal-title":"Ann Neurol."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0545","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3233\/JAD-2007-12305","article-title":"Mercaptopropionaldehyde from homocysteine: implications for Alzheimer's disease","volume":"12","author":"Toohey","year":"2007","journal-title":"J Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0550","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0197-4580(00)00111-1","article-title":"Critically attained threshold of cerebral hypoperfusion: the CATCH hypothesis of Alzheimer's pathogenesis","volume":"21","author":"de la Torre","year":"2000","journal-title":"Neurobiol Aging."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.06.018_b0555","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S1474-4422(06)70598-1","article-title":"Vitamin B12, folic acid, and the nervous system","volume":"5","author":"Reynolds","year":"2006","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.06.018_b0560","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3233\/JAD-201481","article-title":"Association between Homocysteine and vitamin levels in demented patients","volume":"81","author":"Hoffmann","year":"2021","journal-title":"J Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.06.018_b0565","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/jhn.12636","article-title":"Association of vitamin D and vitamin B(12) with cognitive impairment in elderly aged 80years or older: a cross-sectional study","volume":"32","author":"da Rosa","year":"2019","journal-title":"J Hum Nutr Diet."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0570","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11130-013-0370-0","article-title":"Dietary antioxidants, cognitive function and dementia\u2013a systematic review","volume":"68","author":"Crichton","year":"2013","journal-title":"Plant Foods Hum Nutr."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0575","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-510X(02)00290-3","article-title":"Plasma antioxidant activity and vascular dementia","volume":"203\u2013204","author":"Ryglewicz","year":"2002","journal-title":"J Neurol Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0580","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0304-3940(94)90122-8","article-title":"Concentrations of alpha-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the binswanger type and Alzheimer type dementia","volume":"174","author":"Tohgi","year":"1994","journal-title":"Neurosci Lett."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.06.018_b0585","article-title":"Superoxide dismutase\u2013applications and relevance to human diseases","volume":"8","author":"Noor","year":"2002","journal-title":"Med Sci Monit."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0590","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-510X(97)00172-X","article-title":"Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia","volume":"153","author":"Ihara","year":"1997","journal-title":"J Neurol Sci."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.06.018_b0595","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s007020170003","article-title":"Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients","volume":"108","author":"Serra","year":"2001","journal-title":"J Neural Transm (vienna)."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.06.018_b0600","doi-asserted-by":"crossref","first-page":"834","DOI":"10.14336\/AD.2019.0304","article-title":"Plasma lipoprotein-associated phospholipase A2 and superoxide dismutase are independent predicators of cognitive impairment in cerebral small vessel disease patients: diagnosis and assessment","volume":"10","author":"Zhu","year":"2019","journal-title":"Aging Dis."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0605","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2021.717008","article-title":"Puerarin alleviates Vascular cognitive impairment in Vascular dementia rats","volume":"15","author":"Zhu","year":"2021","journal-title":"Front Behav Neurosci."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0610","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.brainresbull.2017.04.019","article-title":"The protective effect of astaxanthin on learning and memory deficits and oxidative stress in a mouse model of repeated cerebral ischemia\/reperfusion","volume":"131","author":"Xue","year":"2017","journal-title":"Brain Res Bull."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0615","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fnagi.2017.00026","article-title":"Plasma cystatin C and high-density lipoprotein are important Biomarkers of Alzheimer's disease and Vascular dementia: a cross-sectional study","volume":"9","author":"Wang","year":"2017","journal-title":"Front Aging Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2025.06.018_b0620","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jns.2009.02.344","article-title":"Vascular and biochemical risk factors of vascular dementia after lacunar strokes (S-VaD) and after multiinfarcts in strategic areas (M-VaD)","volume":"283","author":"Graban","year":"2009","journal-title":"J Neurol Sci."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0625","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3233\/JAD-191111","article-title":"Uric acid and high-density lipoprotein cholesterol are differently associated with Alzheimer's disease and Vascular dementia","volume":"73","author":"Liu","year":"2020","journal-title":"J Alzheimers Dis."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.06.018_b0630","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.drudis.2021.03.016","article-title":"Pathophysiology and inhibition of cholesteryl ester transfer protein for prevention of cardiovascular diseases: an update","volume":"26","author":"Banerjee","year":"2021","journal-title":"Drug Discov Today."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.06.018_b0635","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00702-008-0180-y","article-title":"Association of CETP polymorphisms with the risk of vascular dementia and white matter lesions","volume":"116","author":"Qureischie","year":"2009","journal-title":"J Neural Transm (vienna)."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0640","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nat Rev Cardiol."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.06.018_b0645","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041505","article-title":"Lipids and Alzheimer's disease","volume":"21","author":"Kao","year":"2020","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0650","doi-asserted-by":"crossref","unstructured":"Koldamova R, Fitz NF, Lefterov I. ATP-binding cassette transporter A1: from metabolism to neurodegeneration. Neurobiol Dis. 2014, 72 Pt A: 13-21. DOI:10.1016\/j.nbd.2014.05.007.","DOI":"10.1016\/j.nbd.2014.05.007"},{"key":"10.1016\/j.neuroscience.2025.06.018_b0655","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.brainresbull.2013.11.004","article-title":"Dynamic changes of apo A1 mediated by LXR\/RXR\/ABCA1 pathway in brains of the aging rats with cerebral hypoperfusion","volume":"100","author":"Wang","year":"2014","journal-title":"Brain Res Bull."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0660","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/jama.282.3.254","article-title":"Low-density lipoprotein cholesterol and the risk of dementia with stroke","volume":"282","author":"Moroney","year":"1999","journal-title":"Jama."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0665","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/clinchem\/hvaa252","article-title":"Residual Cardiovascular risk at low LDL: remnants, lipoprotein(a), and inflammation","volume":"67","author":"Hoogeveen","year":"2021","journal-title":"Clin Chem."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0670","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3109\/10408363.2014.992063","article-title":"Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases","volume":"52","author":"Trpkovic","year":"2015","journal-title":"Crit Rev Clin Lab Sci."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.06.018_b0675","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.neurobiolaging.2014.02.007","article-title":"Plasma oxidized low-density lipoprotein levels and risk of Alzheimer's disease","volume":"35","author":"Murr","year":"2014","journal-title":"Neurobiol Aging."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0680","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/dmrr.694","article-title":"Small, dense low-density-lipoproteins and the metabolic syndrome","volume":"23","author":"Rizzo","year":"2007","journal-title":"Diabetes Metab Res Rev."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.06.018_b0685","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.metabol.2003.11.020","article-title":"Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia","volume":"53","author":"Watanabe","year":"2004","journal-title":"Metabolism."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.06.018_b0690","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","article-title":"Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector","volume":"24","author":"Wang","year":"2018","journal-title":"Nat Med."},{"issue":"7355","key":"10.1016\/j.neuroscience.2025.06.018_b0695","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/475S20a","article-title":"Genetics: finding risk factors","volume":"475","author":"Eisenstein","year":"2011","journal-title":"Nature."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0700","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2012.02.031","article-title":"Association between apolipoprotein E gene polymorphism and the risk of vascular dementia: a meta-analysis","volume":"514","author":"Yin","year":"2012","journal-title":"Neurosci Lett."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.116606","article-title":"Apolipoprotein E \u03b54 allele is associated with vascular cognitive impairment no dementia in chinese population","volume":"409","author":"Han","year":"2020","journal-title":"J Neurol Sci."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.06.018_b0710","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/gerona\/glab195","article-title":"Metabolic syndrome is associated with poor cognition: a population-based study of 70-Year-old adults without dementia","volume":"76","author":"Marseglia","year":"2021","journal-title":"J Gerontol A Biol Sci Med Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0715","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2010.07.063","article-title":"Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia","volume":"483","author":"McGuinness","year":"2010","journal-title":"Neurosci Lett."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0720","first-page":"938","article-title":"Apolipoprotein E pathology in vascular dementia","volume":"7","author":"Rohn","year":"2014","journal-title":"Int J Clin Exp Pathol."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0725","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3389\/fnagi.2018.00303","article-title":"Bilateral implantation of Shear stress modifier in ApoE knockout mouse induces cognitive impairment and tau abnormalities","volume":"10","author":"Nie","year":"2018","journal-title":"Front Aging Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0730","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/s41598-017-02046-y","article-title":"Protective effects of APOE e2 against disease progression in subcortical vascular mild cognitive impairment patients: a three-year longitudinal study","volume":"7","author":"Kim","year":"2017","journal-title":"Sci Rep."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0735","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1590\/1980-57642021dn15-010007","article-title":"Vascular mild cognitive impairment and its relationship to hemoglobin A1c levels and apolipoprotein E genotypes in the Dominican Republic","volume":"15","author":"Medrano","year":"2021","journal-title":"Dement Neuropsychol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0740","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gene.2015.04.088","article-title":"Human paraoxonase-1 (PON1): gene structure and expression, promiscuous activities and multiple physiological roles","volume":"567","author":"Mackness","year":"2015","journal-title":"Gene."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0745","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1749-6632.2002.tb04802.x","article-title":"Paraoxonase 1 activity: a new vascular marker of dementia?","volume":"977","author":"Dantoine","year":"2002","journal-title":"Ann N Y Acad Sci."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0750","doi-asserted-by":"crossref","first-page":"238","DOI":"10.23736\/S0026-4806.18.05875-5","article-title":"Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development","volume":"110","author":"Cervellati","year":"2019","journal-title":"Minerva Med."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.06.018_b0755","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3390\/antiox9121224","article-title":"HDL proteome and Alzheimer's disease: evidence of a link","volume":"9","author":"Marsillach","year":"2020","journal-title":"Antioxidants (basel)."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.06.018_b0760","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3390\/antiox9050456","article-title":"Arylesterase activity of Paraoxonase-1 in serum and cerebrospinal fluid of patients with Alzheimer's disease and Vascular dementia","volume":"9","author":"Romani","year":"2020","journal-title":"Antioxidants (basel)."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.06.018_b0765","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.12.047","article-title":"Effect of yokukansan on nitric oxide production and hydroxyl radical metabolism during cerebral ischemia and reperfusion in mice","volume":"28","author":"Kitabayashi","year":"2019","journal-title":"J Stroke Cerebrovasc Dis."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.06.018_b0770","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.freeradbiomed.2004.09.017","article-title":"Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?","volume":"38","author":"Kadiiska","year":"2005","journal-title":"Free Radic Biol Med."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0775","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1017\/S0317167100012701","article-title":"Biomarkers of oxidative stress in vascular dementia patients","volume":"39","author":"Shi","year":"2012","journal-title":"Can J Neurol Sci."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0780","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijcard.2015.01.043","article-title":"Urinary biomarkers of oxidative and nitrosative stress and the risk for incident stroke: a nested case-control study from a community-based cohort","volume":"183","author":"Lin","year":"2015","journal-title":"Int J Cardiol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0785","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7762\/cnr.2018.7.1.1","article-title":"Perspectives in Lipocalin-2: Emerging Biomarker for Medical diagnosis and prognosis for Alzheimer's disease","volume":"7","author":"Song","year":"2018","journal-title":"Clin Nutr Res."},{"issue":"1\u20132","key":"10.1016\/j.neuroscience.2025.06.018_b0790","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jns.2011.03.023","article-title":"Increased plasma levels of lipocalin 2 in mild cognitive impairment","volume":"305","author":"Choi","year":"2011","journal-title":"J Neurol Sci."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0795","article-title":"Sailuotong capsule prevents the cerebral ischaemia-induced neuroinflammation and impairment of recognition memory through inhibition of LCN2 expression","volume":"2019","author":"Zhang","year":"2019","journal-title":"Oxid Med Cell Longev."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.06.018_b0800","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/glia.23174","article-title":"Astrocyte-derived lipocalin-2 mediates hippocampal damage and cognitive deficits in experimental models of vascular dementia","volume":"65","author":"Kim","year":"2017","journal-title":"Glia."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.06.018_b0805","first-page":"6717","article-title":"Correlation of serum uric acid, cystatin C and high-sensitivity C-reactive protein with cognitive impairment in lacunar cerebral infarction","volume":"13","author":"Wanggong","year":"2021","journal-title":"Am J Transl Res."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0810","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.553998","article-title":"Inflammation, cognition, and white matter in older adults: an examination by race","volume":"12","author":"Boots","year":"2020","journal-title":"Front Aging Neurosci."},{"issue":"11","key":"10.1016\/j.neuroscience.2025.06.018_b0815","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1161\/STROKEAHA.118.022317","article-title":"C-reactive protein, plasma amyloid-\u03b2 levels, and their Interaction with magnetic resonance imaging Markers","volume":"49","author":"Hilal","year":"2018","journal-title":"Stroke."},{"issue":"13","key":"10.1016\/j.neuroscience.2025.06.018_b0820","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1212\/WNL.0b013e3181d7b45b","article-title":"Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function","volume":"74","author":"Wersching","year":"2010","journal-title":"Neurology."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.06.018_b0825","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jnnp-2021-327462","article-title":"CAIDE dementia risk score relates to severity and progression of cerebral small vessel disease in healthy midlife adults: the PREVENT-dementia study","volume":"93","author":"Low","year":"2022","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"4(Suppl.)","key":"10.1016\/j.neuroscience.2025.06.018_b0830","first-page":"1445","article-title":"Clinical research of homocysteine, high-sensitive C-reactive protein and D-Dimer in patients with vascular dementia","volume":"30","author":"Zhang","year":"2017","journal-title":"Pak J Pharm Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0835","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3988\/jcn.2018.14.1.29","article-title":"Different associations of plasma Biomarkers in Alzheimer's disease, mild cognitive impairment, Vascular dementia, and ischemic stroke","volume":"14","author":"Shang","year":"2018","journal-title":"J Clin Neurol."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0840","doi-asserted-by":"crossref","first-page":"277.e7","DOI":"10.1016\/j.jamda.2016.12.006","article-title":"C-reactive protein predicts incidence of dementia in an elderly asian community cohort","volume":"18","author":"Hsu","year":"2017","journal-title":"J Am Med Dir Assoc."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0845","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ajp.2017.04.015","article-title":"Role of inflammatory and hemostatic biomarkers in Alzheimer's and vascular dementia - a pilot study from a tertiary center in northern India","volume":"29","author":"Vishnu","year":"2017","journal-title":"Asian J Psychiatr."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0850","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.acc.2019.01.002","article-title":"Acute phase reactant serum amyloid a in inflammation and other diseases","volume":"90","author":"Zhang","year":"2019","journal-title":"Adv Clin Chem."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0855","article-title":"The relationship between serum amyloid a level and cognitive dysfunction in patients with Vascular dementia: Preliminary findings","volume":"2021","author":"Xu","year":"2021","journal-title":"Biomed Res Int."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577466","article-title":"Serum amyloid a level correlates with T2 lesion volume and cortical volume in patients with multiple sclerosis","volume":"351","author":"Yokote","year":"2021","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0865","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.725511","article-title":"Serum amyloid Biomarkers, tau protein and YKL-40 utility in detection, differential diagnosing, and monitoring of dementia","volume":"12","author":"Wilczy\u0144ska","year":"2021","journal-title":"Front Psychiatry."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.06.018_b0870","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1161\/HYPERTENSIONAHA.119.14553","article-title":"Visit-to-visit blood pressure Variability is associated with cognitive decline and incident dementia: the S.AGES cohort","volume":"76","author":"Rouch","year":"2020","journal-title":"Hypertension."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0875","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/CIRCULATIONAHA.111.063842","article-title":"Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease","volume":"125","author":"Sabatine","year":"2012","journal-title":"Circulation."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0880","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ehf2.12231","article-title":"Prognostic performance of serial in-hospital measurements of copeptin and multiple novel biomarkers among patients with worsening heart failure: results from the MOLITOR study","volume":"5","author":"D\u00fcngen","year":"2018","journal-title":"ESC Heart Fail."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.06.018_b0885","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1161\/HYPERTENSIONAHA.109.147389","article-title":"Lowering midlife levels of systolic blood pressure as a public health strategy to reduce late-life dementia: perspective from the Honolulu Heart program\/Honolulu Asia aging study","volume":"55","author":"Launer","year":"2010","journal-title":"Hypertension."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0890","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/joim.12621","article-title":"Biomarkers of microvascular endothelial dysfunction predict incident dementia: a population-based prospective study","volume":"282","author":"Holm","year":"2017","journal-title":"J Intern Med."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.06.018_b0895","first-page":"796","article-title":"Inflammatory Biomarkers predict domain-specific cognitive decline in older adults","volume":"72","author":"Chi","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci."},{"issue":"Pt 5","key":"10.1016\/j.neuroscience.2025.06.018_b0900","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/brain\/awu040","article-title":"Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia","volume":"137","author":"Barker","year":"2014","journal-title":"Brain."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.06.018_b0905","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/gps.4964","article-title":"The association between orthostatic hypotension and dementia: a meta-analysis of prospective cohort studies","volume":"33","author":"Min","year":"2018","journal-title":"Int J Geriatr Psychiatry."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0910","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3233\/JAD-190402","article-title":"Orthostatic hypotension: an important risk factor for clinical progression to mild cognitive impairment or dementia. the Amsterdam dementia cohort","volume":"71","author":"Kleipool","year":"2019","journal-title":"J Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.06.018_b0915","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/joim.12043","article-title":"Novel cardiovascular biomarkers in unexplained syncopal attacks: the SYSTEMA cohort","volume":"273","author":"Fedorowski","year":"2013","journal-title":"J Intern Med."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0920","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11154-019-09509-9","article-title":"Vasopressin and copeptin in health and disease","volume":"20","author":"Christ-Crain","year":"2019","journal-title":"Rev Endocr Metab Disord."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0925","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2147\/PRBM.S192951","article-title":"Sexual dimorphism of oxytocin and vasopressin in social cognition and behavior","volume":"12","author":"Lu","year":"2019","journal-title":"Psychol Res Behav Manag."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0930","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fped.2016.00075","article-title":"Arginine vasopressin and copeptin in perinatology","volume":"4","author":"Evers","year":"2016","journal-title":"Front Pediatr."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0935","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3233\/JAD-151118","article-title":"Copeptin, a Marker of vasopressin, predicts Vascular dementia but not Alzheimer's disease","volume":"52","author":"Nilsson","year":"2016","journal-title":"J Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.06.018_b0940","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1523\/JNEUROSCI.14-04-02225.1994","article-title":"Increased levels of hemoglobin-derived and other peptides in Alzheimer's disease cerebellum","volume":"14","author":"Slemmon","year":"1994","journal-title":"J Neurosci."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0945","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3233\/JAD-200168","article-title":"Cerebrospinal fluid\/plasma albumin ratio as a Biomarker for blood-brain Barrier impairment across neurodegenerative dementias","volume":"75","author":"Musaeus","year":"2020","journal-title":"J Alzheimers Dis."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0950","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurobiolaging.2017.06.028","article-title":"CSF\/serum albumin ratio in dementias: a cross-sectional study on 1861 patients","volume":"59","author":"Skillb\u00e4ck","year":"2017","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0955","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neurobiolaging.2016.11.017","article-title":"Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype","volume":"51","author":"Janelidze","year":"2017","journal-title":"Neurobiol Aging."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0960","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.689938","article-title":"Neurofilament proteins as Biomarkers to monitor neurological diseases and the efficacy of therapies","volume":"15","author":"Yuan","year":"2021","journal-title":"Front Neurosci."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b0965","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40291-021-00566-y","article-title":"Neurofilament light chain as a Biomarker in cerebral small-vessel disease","volume":"26","author":"Peters","year":"2022","journal-title":"Mol Diagn Ther."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b0970","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5853\/jos.2017.02565","article-title":"Serum neurofilament light chain levels are related to small vessel disease burden","volume":"20","author":"Duering","year":"2018","journal-title":"J Stroke."},{"key":"10.1016\/j.neuroscience.2025.06.018_b0975","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6612871","article-title":"Elevated levels of serum neurofilament light chain associated with cognitive impairment in Vascular dementia","volume":"2020","author":"Ma","year":"2020","journal-title":"Dis Markers."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.06.018_b0980","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/jnnp-2020-325681","article-title":"Neurofilament light chain predicts future dementia risk in cerebral small vessel disease","volume":"92","author":"Egle","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0985","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5853\/jos.2019.02845","article-title":"Serum neurofilament light chain is associated with incident lacunes in progressive cerebral small vessel disease","volume":"22","author":"Peters","year":"2020","journal-title":"J Stroke."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b0990","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/jnen\/nlab134","article-title":"Vasculocentric axonal NfH in small vessel disease","volume":"81","author":"Anad","year":"2022","journal-title":"J Neuropathol Exp Neurol."},{"issue":"24","key":"10.1016\/j.neuroscience.2025.06.018_b0995","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1161\/01.CIR.0000133311.25587.DE","article-title":"Circulating CD34-positive cells provide an index of cerebrovascular function","volume":"109","author":"Taguchi","year":"2004","journal-title":"Circulation."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b1000","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.jcbfm.9600541","article-title":"Circulating CD34-positive cells provide a marker of vascular risk associated with cognitive impairment","volume":"28","author":"Taguchi","year":"2008","journal-title":"J Cereb Blood Flow Metab."},{"issue":"13","key":"10.1016\/j.neuroscience.2025.06.018_b1005","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1523\/JNEUROSCI.5165-05.2006","article-title":"Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats","volume":"26","author":"Shyu","year":"2006","journal-title":"J Neurosci."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.06.018_b1010","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.3390\/jcm9072248","article-title":"Endothelial progenitor cells as a Marker of Vascular damage but not a predictor in acute microangiopathy-associated stroke","volume":"9","author":"Wi\u015bniewski","year":"2020","journal-title":"J Clin Med."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.06.018_b1015","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat Rev Genet."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.06.018_b1020","doi-asserted-by":"crossref","first-page":"744","DOI":"10.2174\/1567201813666160830124627","article-title":"Role of microRNAs on blood brain Barrier dysfunction in Vascular cognitive impairment","volume":"14","author":"Toyama","year":"2017","journal-title":"Curr Drug Deliv."},{"issue":"12","key":"10.1016\/j.neuroscience.2025.06.018_b1025","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/cns.13472","article-title":"Regulatory microRNAs and vascular cognitive impairment and dementia","volume":"26","author":"Zhang","year":"2020","journal-title":"CNS Neurosci Ther."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.06.018_b1030","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/ageing\/afx090","article-title":"Circulating microRNAs as potential biomarkers for the identification of vascular dementia due to cerebral small vessel disease","volume":"46","author":"Prabhakar","year":"2017","journal-title":"Age Ageing."},{"key":"10.1016\/j.neuroscience.2025.06.018_b1035","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/625659","article-title":"Serum MicroRNA profiles serve as novel Biomarkers for the diagnosis of Alzheimer's disease","volume":"2015","author":"Dong","year":"2015","journal-title":"Dis Markers."},{"issue":"8","key":"10.1016\/j.neuroscience.2025.06.018_b1040","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.18632\/aging.101925","article-title":"Diagnostic performance of new and classic CSF biomarkers in age-related dementias","volume":"11","author":"Marchegiani","year":"2019","journal-title":"Aging (albany NY)."},{"key":"10.1016\/j.neuroscience.2025.06.018_b1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113528","article-title":"Inhibition of the BCL6\/miR-31\/PKD1 axis attenuates oxidative stress-induced neuronal damage","volume":"335","author":"Wei","year":"2021","journal-title":"Exp Neurol."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.06.018_b1050","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.3892\/etm.2017.4874","article-title":"MicroRNA-93 inhibits inflammatory responses and cell apoptosis after cerebral ischemia reperfusion by targeting interleukin-1 receptor-associated kinase 4","volume":"14","author":"Tian","year":"2017","journal-title":"Exp Ther Med."},{"key":"10.1016\/j.neuroscience.2025.06.018_b1055","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.nbd.2019.01.019","article-title":"MiR-146a promotes oligodendrocyte progenitor cell differentiation and enhances remyelination in a model of experimental autoimmune encephalomyelitis","volume":"125","author":"Zhang","year":"2019","journal-title":"Neurobiol Dis."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b1060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/glia.23530","article-title":"MiR-409-3p and MiR-1896 co-operatively participate in IL-17-induced inflammatory cytokine production in astrocytes and pathogenesis of EAE mice via targeting SOCS3\/STAT3 signaling","volume":"67","author":"Liu","year":"2019","journal-title":"Glia."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.06.018_b1065","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/ATVBAHA.118.310822","article-title":"MicroRNA-mediated therapy modulating blood-brain Barrier disruption improves Vascular cognitive impairment","volume":"38","author":"Toyama","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b1070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40478-017-0414-z","article-title":"Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease","volume":"5","author":"Hara","year":"2017","journal-title":"Acta Neuropathol Commun."},{"issue":"10","key":"10.1016\/j.neuroscience.2025.06.018_b1075","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1779","article-title":"Association between serum NPTX2 and cognitive function in patients with vascular dementia","volume":"10","author":"Shao","year":"2020","journal-title":"Brain Behav."},{"issue":"6","key":"10.1016\/j.neuroscience.2025.06.018_b1080","first-page":"849","article-title":"Plasma osteoprotegerin as a biochemical marker for vascular dementia and Alzheimer's disease","volume":"13","author":"Emanuele","year":"2004","journal-title":"Int J Mol Med."},{"key":"10.1016\/j.neuroscience.2025.06.018_b1085","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.880148","article-title":"Higher serum soluble TREM2 as a potential indicative Biomarker for cognitive impairment in inadequately controlled type 2 diabetes without obesity: the DOR-KyotoJ-1","volume":"13","author":"Tanaka","year":"2022","journal-title":"Front Endocrinol (lausanne)."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b1090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/psyg.12452","article-title":"Relationship between normal weight obesity and mild cognitive impairment is reflected in cognitive-related genes in human peripheral blood mononuclear cells","volume":"20","author":"Zhang","year":"2020","journal-title":"Psychogeriatrics."},{"issue":"2","key":"10.1016\/j.neuroscience.2025.06.018_b1095","doi-asserted-by":"crossref","first-page":"H740","DOI":"10.1152\/ajpheart.00736.2020","article-title":"Obesity-induced cognitive impairment in older adults: a microvascular perspective","volume":"320","author":"Balasubramanian","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"7","key":"10.1016\/j.neuroscience.2025.06.018_b1100","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3390\/nu16070952","article-title":"Accelerated aging induced by an unhealthy high-fat diet: initial evidence for the role of Nrf2 deficiency and impaired stress resilience in Cellular senescence","volume":"16","author":"Balasubramanian","year":"2024","journal-title":"Nutrients."},{"key":"10.1016\/j.neuroscience.2025.06.018_b1105","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103822","article-title":"Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: a scoping review","volume":"180","author":"Oppegaard","year":"2022","journal-title":"Crit Rev Oncol Hematol."},{"issue":"4","key":"10.1016\/j.neuroscience.2025.06.018_b1110","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11764-020-00863-1","article-title":"Functional connectome biotypes of chemotherapy-related cognitive impairment","volume":"14","author":"Kesler","year":"2020","journal-title":"J Cancer Surviv."},{"key":"10.1016\/j.neuroscience.2025.06.018_b1115","article-title":"The correlation between neutrophil-to-lymphocyte ratio, carcinoembryonic antigen, and carbohydrate antigen 153 levels with chemotherapy-related cognitive impairment in early-stage breast cancer patients","volume":"9","author":"Yu","year":"2022","journal-title":"Front Med (lausanne)."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b1120","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/10428194.2024.2424373","article-title":"Deranged cytokine levels are linked to cancer-related cognitive impairment in lymphoma patients receiving R-CHOP chemotherapy","volume":"66","author":"Mishra","year":"2025","journal-title":"Leuk Lymphoma."},{"issue":"3","key":"10.1016\/j.neuroscience.2025.06.018_b1125","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11481-023-10062-1","article-title":"L-carnitine modulates cognitive impairment induced by doxorubicin and cyclophosphamide in rats; insights to oxidative stress, inflammation, synaptic plasticity, liver\/brain, and kidney\/brain axes","volume":"18","author":"Morid","year":"2023","journal-title":"J Neuroimmune Pharmacol."},{"issue":"5","key":"10.1016\/j.neuroscience.2025.06.018_b1130","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1007\/s11357-023-00870-x","article-title":"Elimination of senescent cells by treatment with Navitoclax\/ABT263 reverses whole brain irradiation-induced blood-brain barrier disruption in the mouse brain","volume":"45","author":"Gulej","year":"2023","journal-title":"Geroscience."},{"key":"10.1016\/j.neuroscience.2025.06.018_b1135","doi-asserted-by":"crossref","unstructured":"Patai R, Csik B, Nyul-Toth A, et al. Persisting blood-brain barrier disruption following cisplatin treatment in a mouse model of chemotherapy-associated cognitive impairment. Geroscience. 2025. Epub ahead of print. DOI:10.1007\/s11357-025-01569-x.","DOI":"10.1007\/s11357-025-01569-x"},{"issue":"7","key":"10.1016\/j.neuroscience.2025.06.018_b1140","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13832","article-title":"Accelerated cerebromicrovascular senescence contributes to cognitive decline in a mouse model of paclitaxel (taxol)-induced chemobrain","volume":"22","author":"Ahire","year":"2023","journal-title":"Aging Cell."},{"issue":"1","key":"10.1016\/j.neuroscience.2025.06.018_b1145","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1186\/s12888-022-04420-1","article-title":"Obesity marker trajectories and cognitive impairment in older adults: a 10-year follow-up in taichung community health study for elders","volume":"22","author":"Li","year":"2022","journal-title":"BMC Psychiatry."},{"key":"10.1016\/j.neuroscience.2025.06.018_b1150","doi-asserted-by":"crossref","DOI":"10.1177\/15347354221140498","article-title":"The managing cancer and living meaningfully (CALM) intervention alleviates chemotherapy-related cognitive impairment in patients with breast cancer by modulating Pan-immune-inflammation values","volume":"21","author":"Yao","year":"2022","journal-title":"Integr Cancer Ther."},{"issue":"9","key":"10.1016\/j.neuroscience.2025.06.018_b1155","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1038\/mp.2017.204","article-title":"Blood-derived amyloid-\u03b2 protein induces Alzheimer's disease pathologies","volume":"23","author":"Bu","year":"2018","journal-title":"Mol Psychiatry."},{"key":"10.1016\/j.neuroscience.2025.06.018_b1160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.exger.2017.12.019","article-title":"Role of the peripheral innate immune system in the development of Alzheimer's disease","volume":"107","author":"Le Page","year":"2018","journal-title":"Exp Gerontol."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225007006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452225007006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T21:40:33Z","timestamp":1762292433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452225007006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":232,"alternative-id":["S0306452225007006"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.06.018","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluid biomarkers of vascular cognitive Impairment: From vascular pathophysiology to potential clinical applications","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2025.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}